Latest Insights on BB
Profit as Robots Infiltrate Farming With This 1 ETF August 17, 2021 Big Picture. Big Profits., Technology, U.S. Economy In yesterday’s Your Money Matters video, Angela Jirau, Clint Lee and I talked about the revolutionary potential of automation and robotics to increase productivity in the U.S. economy in the coming decade.
Increasing productivity — getting more from an hour of labor — is a solution to almost every economic problem.
In the long run, population and productivity growth drive economic growth. Given a fixed amount of capital and labor, growing productivity is the only way to increase output.
Tesla Tears & Nio’s Next, Sonos Breaks The Silence, China’s Tech Terror August 16, 2021 Great Stuff Go Home, Tesla … You’re Drunk? Oh oh, here they come. Watch out, Tesla (Nasdaq: ), they’ll chew you up. Oh oh, here they come… The National Highway Traffic Safety Administration (NHTSA) is far from a maneater … sorry, Hall & Oates … but it is about to make Tesla’s life much more complicated. This […]
Profit From the Coming Surge in Robotics and Automation August 16, 2021 Big Picture. Big Profits., News, Technology, U.S. Economy The delta variant is draining the global economy and destroying consumer confidence. Democrats are struggling to get their infrastructure bill through. And recovery stocks are suffering as a result. But today, we look beyond the bad news and explore the opportunities waiting on the other side.
The Mouse’s Fury, Whiffed Wishes and Canadian Railroad Dreams August 13, 2021 Great Stuff Friday Four Play: The “Happiest Place On Earth” Edition Just like Jason Voorhees, Walt Disney (NYSE: ) just won’t stay down for long. And today’s quarterly report raised the Mouse’s House from the proverbial grave once again. Now, since Disney is a Great Stuff Picks portfolio holding, you know I never thought Disney was dead […]
The Secret to Investing Safely in Biotech August 13, 2021 Big Picture. Big Profits., Technology, U.S. Economy Biotech is back — new vaccines, new technologies. It's certainly tempting for the average investor to try to stake a claim right now. But as enticing as those stories about lifesaving drugs and potential profits may seem, biotech investing is risky business. I learned a painful — but powerful — lesson myself that I'd like to share with you. In today’s video, you'll see that there is a better, safer way to play this biotech boom ... all while collecting enormous dividends.MEET OUR EXPERTS
Chief Investment Strategist of Money & Markets
Chief Strategist of Strategic Fortunes and three elite services
Director of VIP Services
Founder of TRADEMONSTER.ai
Founder of Weekend Trader
Research Analyst
